Table.
Anti-Nipah antibodies among symptomatic survivors of Nipah virus infection and their asymptomatic contacts from Kerala, India
Post-onset of disease/days post-exposure | Anti-NiV IgM | Anti-NiV IgG | ||
---|---|---|---|---|
|
|
|||
Number of samples | Average OD (±SD) | Number of samples | Average OD±SD | |
0-7 | 3 | 0.81±0.24 | 3 | 0.352±0.03 |
8-14 | 11 | 0.33±0.11 | 11 | 0.4±0.07 |
15-21 | 5 | 0.38±0.11 | 5 | 0.55±0.15 |
22-28 | 3 | 0.41±0.041 | 3 | 0.56±0.05 |
29-35 | 1 | 0.6 | 1 | 0.65 |
36-60 | 5 | 0.26±0.189 | 5 | 0.59±0.37 |
61-180 | 4 | 0.36 | 4 | 0.62±0.48 |
181-365 | 4 | ND | 4 | 0.59±0.06 |
366-476 | 4 | ND | 4 | 0.95±0.27 |
IgM cut-off: 0.20 and IgG cut-off: 0.35. OD, optical density; ND, not detected; SD, standard deviation; Ig, immunoglobulin; NiV, Nipah virus